How the BioHealth Capital Region, Philadelphia, and Research Triangle Park are Backing the White House Cancer Moonshot Initiative By Alex KeownJune 6, 2023 It takes a community to take on [….]
Chimerix Sees Promise to Treat Brain Tumors With Imipridone Platform By Alex KeownMay 11, 2023 Chimerix Inc. is highly confident in the outcomes of the Phase III ACTION study assessing [….]
Weekly Quick Hits (Research Triangle Park) – Week of April 17, 2023 By Alex Keown, Mark Terry, and Sarah EllinwoodApril 21, 2023 In the Clinic Renovion, Inc. Enrolls First Patient [….]
Chimerix Advances ONC201 toward Regulatory Approval By Alex KeownMarch 4, 2023 Bolstered by positive Phase II data, Chimerix, Inc. remains on track for full enrollment in its Phase III ACTION [….]
